edoc-vmtest

Novel diamidines with activity against Babesia divergens in Vitro and Babesia microti in Vivo

Nehrbass-Stuedli A., and Boykin, D. and Tidwell, R. R. and Brun, R.. (2011) Novel diamidines with activity against Babesia divergens in Vitro and Babesia microti in Vivo. Antimicrobial agents and chemotherapy : AAC, Vol. 55, H. 7. pp. 3439-3445.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6002287

Downloads: Statistics Overview

Abstract

Dicationic diamidines, such as diminazene and pentamidine, are well-studied chemotherapeutic agents with significant activity against parasitic diseases. The in vitro activities of novel diamidine compounds against the Babesia divergens strains 1903B and 4201 were investigated. The most potent compound, a diphenyl furan, had a 50% inhibitory concentration (IC(50)) of 1.5 ng/ml. In a murine model, several test compounds were effective enough to cure mice infected with Babesia microti at a dose of 12.5 and/or 25 mg/kg of body weight given by the subcutaneous route for 4 days. The best antibabesial properties were exhibited by terphenyls, benzimidazoles, diphenyl furans, pentamidine, and pentamidine analogues
Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Parasite Chemotherapy (Mäser)
UniBasel Contributors:Brun, Reto
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:American Society for Microbiology
ISSN:0066-4804
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:08 Nov 2012 16:22
Deposited On:08 Nov 2012 16:08

Repository Staff Only: item control page